The University of Dublin | Trinity College -- Ollscoil Átha Cliath | Coláiste na Tríonóide
Trinity's Access to Research Archive
Home :: Log In :: Submit :: Alerts ::

TARA >
School of Medicine >
Clinical Medicine >
Clinical Medicine (Scholarly Publications) >

Please use this identifier to cite or link to this item: http://hdl.handle.net/2262/32919

Title: Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction
Author: FALLON, PADRAIC
O'NEILL, LUKE ANTHONY JOHN
Sponsor: Enterprise Ireland
Author's Homepage: http://people.tcd.ie/pfallon
Keywords: Clinical Medicine
Issue Date: 2002
Publisher: American Society for Biochemistry and Molecular Biology
Citation: Brint, E.K., Fitzgerald, K.A., Smith, P., Coyle, A.J., Gutierrez-Ramos, J-C., Fallon, P.G. and O’Neill, L.A.J. ‘Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction’ in Journal of Biological Chemistry, 277, (51), 2002, pp 49205 - 49211
Series/Report no.: Journal of Biological Chemistry
277
51
Abstract: T1/ST2 is a member of the interleukin (IL)-1 receptor superfamily, possessing three immunoglobulin domains extracellularly and a Toll/IL1R (TIR) domain intracellularly. The ligand for T1/ST2 is not known. T1/ST2 is expressed on Type 2 T helper (Th2) cells, and its role appears to be in the regulation of Th2 cell function. Here, we have investigated T1/ST2 signal transduction, using either transient overexpression of T1/ST2 or a cross-linking monoclonal antibody to activate cells. We demonstrate that T1/ST2 does not activate the transcription factor NF-κB when overexpressed in murine thymoma EL4 cells, or in the mast cell line P815 treated with the anti-T1/ST2 antibody. However, a chimera comprising the extracellular domain of the type 1 IL-1 receptor and the intracellular domain of T1/ST2 activates NF-κB both by overexpression and in response to IL-1. This artificial activation requires the IL1RAcP recruited via the extracellular portion (IL1R1) of the chimera. T1/ST2 is, however, able to activate the transcription factor activator protein-1 (AP-1), increase phosphorylation of c-Jun, and activate the MAP kinases c-Jun N-terminal kinase (JNK), p42/p44 and p38. Anti-T1/ST2 also induces the selective expression of IL-4 but not IFN-γ in naive T cells. Importantly, this effect is blocked by prior treatment with the JNK inhibitor SP600125 confirming that JNK as a key effector in T1/ST2 signaling. The lack of effect on NF-κB when T1/ST2 is homodimerized identifies T1/ST2 as the first member of the IL-1 receptor superfamily so far studied that is apparently unable to activate NF-κB, consistent with evidence indicating the lack of a role for NF-κB in Th2 cell function.
Description: PUBLISHED
URI: http://dx.doi.org/10.1074/jbc.M209685200
http://hdl.handle.net/2262/32919
Appears in Collections:Clinical Medicine (Scholarly Publications)

Files in This Item:

File Description SizeFormat
Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1 ST2. A role for Jun N-terminal kinase in IL-4 induction.pdfpublished (publisher copy) peer-reviewed336.5 kBAdobe PDFView/Open


This item is protected by original copyright


Please note: There is a known bug in some browsers that causes an error when a user tries to view large pdf file within the browser window. If you receive the message "The file is damaged and could not be repaired", please try one of the solutions linked below based on the browser you are using.

Items in TARA are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback